Condition

Nasopharyngeal Carcinoma

ClinicalTrials.gov condition label

Clinical trials22
Recruiting3
Common interventions25
Lead sponsors shown14

Clinical trials

22 shown
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck CancersNCT06479811 · 2025-08-19
RECRUITING
A Study of BL-B01D1+PD-1 Monoclonal Antibody in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsNCT06475300 · 2024-06-25
RECRUITING
A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer, Nasopharyngeal Carcinoma and Other Solid TumorsNCT05956587 · 2024-01-29
RECRUITING
Docetaxel and SX-682 in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma, Salivary Gland Carcinoma, and Advanced Prostate CancerNCT07667400 · 2026-10-12
NOT_YET_RECRUITING
Local Ablation Plus Systemic Therapy for Metachronous Liver and/or Lung Oligometastases From Nasopharyngeal CarcinomaNCT07824856 · 2026-10-01
NOT_YET_RECRUITING
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid MalignanciesNCT05955105 · 2023-07-25
UNKNOWN
89Zr-girentuximab for PET Imaging of CAIX Positive Solid TumorsNCT05563272 · 2023-06-06
TERMINATED
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced CancersNCT05544929 · 2022-10-26
ACTIVE_NOT_RECRUITING
Study of Safety, Pharmacokinetic and Efficacy of APG-5918 in Advanced Solid Tumors or LymphomasNCT05415098 · 2022-09-30
UNKNOWN
Asian Multicenter Prospective Study of ctDNA SequencingNCT05099978 · 2021-11-01
UNKNOWN
The Registry of Oncology Outcomes Associated With Testing and TreatmentNCT04028479 · 2021-05-05
COMPLETED
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099318 in Participants With Advanced Solid TumorsNCT04272034 · 2021-03-26
TERMINATED
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid TumorsNCT04242199 · 2020-09-04
COMPLETED
Haplo / Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells for Relapsed or Refractory Solid TumourNCT04107142 · 2019-12-01
UNKNOWN
A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid TumorsNCT03849469 · 2019-05-29
COMPLETED
Study of Safety and Efficacy of DKY709 Alone or in Combination With PDR001 in Patients With Advanced Solid Tumors.NCT03891953 · 2019-05-07
ACTIVE_NOT_RECRUITING
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)NCT03752398 · 2019-05-01
COMPLETED
Study of INBRX-105 and INBRX-105 With Pembrolizumab in Patients With Solid Tumors Including Head and Neck CancerNCT03809624 · 2019-01-30
TERMINATED
A Study of XmAb®20717 in Subjects With Selected Advanced Solid TumorsNCT03517488 · 2018-07-10
COMPLETED
Study of DC-CTL Combined With CIK for Advanced Solid TumorNCT03047525 · 2017-02-20
UNKNOWN
Nivolumab and Ipilimumab in Treating Patients With Rare TumorsNCT02834013 · 2017-01-30
ACTIVE_NOT_RECRUITING
A Study of Adoptive Immunotherapy With Autologous Tumor Infiltrating Lymphocytes in Solid TumorsNCT01462903 · 2011-09-01
UNKNOWN

Common interventions

BL-B01D1DRUG2PembrolizumabDRUG2[203Pb]VMT-alpha-NETDRUG1[212Pb]VMT-alpha-NETDRUG168Ga-DOTATATEDRUG189Zr-girentuximab for PET/CT imaging of CAIX positive tumorsDIAGNOSTIC_TEST1Adoptive Cell Transfer of NKG2DL-targetting Chimeric Antigen Receptor-grafted Gamma Delta T cellBIOLOGICAL1APG-5918DRUG1Biomarker Testing (L)DIAGNOSTIC_TEST1Biospecimen CollectionPROCEDURE1CisplatinDRUG1Computed TomographyPROCEDURE1CT-guided percutaneous local ablationPROCEDURE1Cytokine-induced Killer CellsBIOLOGICAL1DKY709DRUG1DTXDRUG1Echocardiography TestPROCEDURE1GemcitabineDRUG1ILB-2109DRUG1INBRX-105 - PDL1x41BB antibodyDRUG1INCB099280DRUG1INCB099318DRUG1IpilimumabBIOLOGICAL1KFA115DRUG1Magnetic Resonance ImagingPROCEDURE1

Trial status mix

UNKNOWN6
COMPLETED5
ACTIVE_NOT_RECRUITING3
RECRUITING3
TERMINATED3
NOT_YET_RECRUITING2

Phase mix

PHASE115
PHASE28

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.